You are not currently logged in.
Access JSTOR through your library or other institution:
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Christopher Dye, Brian G. Williams, Marcos A. Espinal and Mario C. Raviglione
New Series, Vol. 295, No. 5562 (Mar. 15, 2002), pp. 2042-2046
Published by: American Association for the Advancement of Science
Stable URL: http://www.jstor.org/stable/3076272
Page Count: 5
You can always find the topics here!Topics: Tuberculosis, Multidrug resistant tuberculosis, Mycobacterium tuberculosis, AIDS, HIV, Genotypes, Epidemics, Infections, Lungs, Epidemiology
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Multidrug-resistant tuberculosis (MDR) is perceived as a growing hazard to human health worldwide. Judgments about the true scale of the problem, and strategies for containing it, need to come from a balanced appraisal of the epidemiological evidence. We conclude in this review that MDR is, and will probably remain, a locally severe problem; that epidemics can be prevented by fully exploiting the potential of standard short-course chemotherapy (SCC) based on cheap and safe first-line drugs; and that best-practice SCC may even reduce the incidence of MDR where it has already become endemic. On the basis of the available, imperfect data, we recommend a three-part response to the threat of MDR: widespread implementation of SCC as the cornerstone of good tuberculosis control, improved resistance testing and surveillance, and the careful introduction of second-line drugs after a sound evaluation of cost, effectiveness, and feasibility.
Science © 2002 American Association for the Advancement of Science